Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check8 days agoChange DetectedRelated topics links for Multiple Myeloma and MedlinePlus Genetics were removed from the page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe DREAMM-3 study locations were updated to add and remove sites, with the page now indicating 102 locations (including Omaha, NE and Shibuya-Ku, Tokyo) and a revision to version 3.4.2.SummaryDifference2%

- Check30 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1 is displayed. This appears to be a non-substantive UI/version update and does not modify study content or parameters.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded Revision: v3.3.4. Removed 'Multiple myeloma' and the related topic 'MedlinePlus Genetics', and removed Revision: v3.3.3.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now includes an additional topic tag for 'Multiple myeloma' and a related topic link to 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.